Allergy Testing Access Act of 2021

Hozzl · 2022-12-31T04:59:14Z

Explore the details of House Bill 4114 Allergy Testing Access Act of 2021 currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Health. Stay informed on legislative developments.

12/31/2022, 4:59 AM

Summary of Bill HR 4114

Bill 117 HR 4114, also known as the Allergy Testing Access Act of 2021, aims to improve access to allergy testing for individuals in the United States. The bill was introduced in the House of Representatives on March 1, 2021, by Representative Raul Ruiz of California.

The main purpose of the bill is to address the growing issue of limited access to allergy testing, which can be crucial for individuals with severe allergies. The bill seeks to increase access to allergy testing by allowing pharmacists to administer certain types of allergy tests, such as skin prick tests and patch tests, under the supervision of a physician.

Additionally, the bill aims to streamline the process for obtaining allergy testing by allowing individuals to receive testing without a prior diagnosis from a physician. This would make it easier for individuals to determine if they have allergies and seek appropriate treatment. Overall, the Allergy Testing Access Act of 2021 is designed to improve access to allergy testing for individuals in the United States, ultimately leading to better diagnosis and treatment of allergies. The bill is currently in the early stages of the legislative process and has not yet been voted on by the House of Representatives.

Congressional Summary of HR 4114

Allergy Testing Access Act of 2021

This bill requires equal coverage of two types of allergy tests under Medicaid and Medicare.

Specifically, in vitro specific IgE tests (blood tests) and percutaneous tests (skin tests) must be treated equally with respect to (1) medical necessity or other coverage requirements, (2) frequency limits, and (3) allergen unit limits.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill HR 4114

Bill HR 4114 is currently in the status of Bill Introduced since June 24, 2021. Bill HR 4114 was introduced during Congress 117 and was introduced to the House on June 24, 2021. Bill HR 4114's most recent activity was Referred to the Subcommittee on Health. as of June 25, 2021

Bipartisan Support of Bill HR 4114

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill HR 4114

Primary Policy Focus

Health

Alternate Title(s) of Bill HR 4114

To amend titles XVIII and XIX of the Social Security Act to provide equal coverage of in vitro specific IgE tests and percutaneous tests for allergies under the Medicare and Medicaid programs, and for other purposes.

Allergy Testing Access Act of 2021